Laennec AI

Laennec AI

At Laennec AI, we are revolutionising the healthcare industry with our cutting-edge, AI-powered Out Patient Devices (OPD) and Self-Driven Healthcare (SDH) technology.

HQ location
Wednesbury, United Kingdom
Website
Launch date
Employees
Enterprise value
$2—3m
Company register number
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor investor

€0.0

round
*

N/A

Grant
Total Funding000k
Notes (0)
More about Laennec AI
Made with AI
Edit

Laennec AI is a Cardiff-based medical technology company founded in 2022 by Dr. Jase John and Dr. Arathy Varghese. The company specializes in developing AI-driven solutions for chronic disease management, specifically by transforming smartphones into digital stethoscopes. This technology allows patients to monitor chronic respiratory and cardiac conditions, such as asthma and COPD, from home.

The co-founders' backgrounds are central to the company's mission. Dr. Jase John, the CEO, is a medical doctor with over a decade of experience who identified the need for better remote body sound analysis during the COVID-19 pandemic. CTO Dr. Arathy Varghese holds a PhD and has extensive R&D experience in AI-sensor integration, contributing to the development of advanced diagnostic tools. Their combined expertise in medicine and technology drives the company's focus on making healthcare more accessible and patient-led.

The core product is a mobile application that uses advanced algorithms to enable users to detect and interpret abnormal respiratory and cardiac sounds with clinical-level accuracy. Key features include guided self-care for proactive health management, remote monitoring by clinicians, and virtual consultations. The business model aims to empower patients to manage their conditions, which can help reduce emergency hospital visits and lessen the workload on healthcare systems like the NHS. The primary clients are patients with chronic conditions, with the technology also targeting healthcare providers, including doctors, nurses, and hospitals for remote patient oversight.

Laennec AI has secured pre-seed funding from investors including SFC Capital and OVC Ventures, in addition to grant funding from organizations such as the Welsh Government, Innovate UK, and the National Institute for Health Research (NIHR). This capital is intended to accelerate the development of their affordable medical devices, conduct clinical trials, and expand market access.

Keywords: digital stethoscope, remote patient monitoring, medical AI, respiratory care, chronic disease management, telehealth, mobile health, MedTech, cardiac monitoring, AI diagnostics

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads